Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous
system (CNS) where immunopathology is thought to be mediated by myelin-reactive CD4+ T …

Multiple sclerosis (MS) is a chronic neurodegenerative disease characterized by the
progressive loss of axonal myelin in several areas of the central nervous system (CNS) that …

Autoimmune diseases, with the exception of rheumatoid arthritis and autoimmune thyroiditis,
are individually rare, but together they affect approximately 5 percent of the population in …

Is there any reason to write a third book on the topic of oxygen-ozone therapy? The first was
written four years ago for italian physicians, who, for some time, had complained about the …

Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …

The immunologic specificity of the antigen receptors of T cells and B cells is the result of
random shuffling of the many genes that form the DNA code for the antigen-binding site of …

Abstract Treatment with glatiramer acetate (GA, copolymer-1, Copaxone), a drug approved
for multiple sclerosis (MS), in a mouse model promoted development of anti-inflammatory …

This book represents the first serious attempt to explain the fundamental basis of
ozonetherapy and is a relevant step towards achieving further progress. Ozone is now …

Multiple sclerosis (MS) is a chronic disease of the CNS that is characterized by inflammation,
demyelination and axonal injury. Although the etiology of MS is still unknown, many findings …

Multiple sclerosis is postulated to be a T cell-mediated autoimmune disease characterised
by a relapsing-remitting stage followed by a secondary progressive phase. The relapsing …